Cytokinetics’ Aficamten Data Could Be Best In Class, Cardiologists Say

CEO Robert Blum Talked To Scrip

 
• By Jessica Merrill
  
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Cardiovascular

More from Therapeutic Category